AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 19(1), 1970, pp. 12-26
Copyright © 1970 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, P. E.
Right arrow Articles by Olszewski, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, P. E.
Right arrow Articles by Olszewski, B.

Antimalarial Activity of 2,4-Diamino-6-[(3,4-Dichlorobenzyl) Nitros-Amino] Quinazoline (CI-679 Base) and CI-679 Acetate

Laboratory Studies in Mice and Rhesus Monkeys

Paul E. Thompson*, Anita Bayles* AND Bronislawa Olszewski
Department of Experimental Therapeutics, Division of Medical and Scientific Affairs, Parke, Davis and Company, Ann Arbor, Michigan 48106

To assess their potential value as antimalarial drugs, we studied CI-679 (base) and CI-679 acetate extensively in oral form and parenteral repository form in mice infected with Plasmodium berghei and in rhesus monkeys infected with Plasmodium cynomolgi. All infections were induced with blood forms of the parasites. Suppressive activity was assayed against four drug-resistant lines of P. berghei. The two drug forms had sufficiently similar effects to permit their being summarized together. The drug was highly effective in mice and monkeys when given either orally or parenterally in repository form. Orally, one large dose or several doses rapidly suppressed the parasitemia and either terminated the infections or suppressed growth of the parasites for many days. The drug caused both nuclear and cytoplasmic damage in asexual forms of P. berghei and P. cynomolgi. A repository dose was active for several weeks in mice and for several months in monkeys. Given orally against P. berghei, the drug 1) was several hundredfold more active than quinine, 2) was effective against a group of lines that collectively are resistant to all suppressive drugs in use and thus appeared to represent a new mode of action, 3) acted synergistically with 4,4'-diaminodiphenylsulfone without apparent commensurate increase in toxicity for mice, and 4) was partially antagonized by para-aminobenzoic acid but not by folinic acid or sodium folate.


* Present address: School of Veterinary Medicine, University of Georgia, Athens, Georgia 30601.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Society of Tropical Medicine and Hygiene.